Axonics Q1 EPS $(0.38) Misses $(0.08) Estimate, Sales $91.41M Beat $89.59M Estimate
Portfolio Pulse from Benzinga Newsdesk
Axonics (NASDAQ:AXNX) reported Q1 EPS of $(0.38), missing the $(0.08) estimate by 375%, and a 100% decrease from last year's $(0.19) per share. However, their quarterly sales of $91.41M exceeded estimates by 2.03%, marking a 29.38% increase from last year's $70.65M.

April 30, 2024 | 8:31 pm
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
Axonics reported a significant miss on EPS estimates but exceeded sales forecasts for Q1, indicating mixed financial health.
The significant miss on EPS estimates could concern investors about profitability, potentially putting downward pressure on the stock. However, the beat on sales estimates and the year-over-year sales growth could offset some of the negative sentiment by demonstrating the company's ability to grow revenue. The mixed financial results make the short-term stock price direction uncertain, hence a neutral score.
CONFIDENCE 90
IMPORTANCE 90
RELEVANCE 100